These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 19473593)
41. Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Raji A; Seely EW; Bekins SA; Williams GH; Simonson DC Diabetes Care; 2003 Jan; 26(1):172-8. PubMed ID: 12502676 [TBL] [Abstract][Full Text] [Related]
42. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade. Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909 [TBL] [Abstract][Full Text] [Related]
43. Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients. Tezcan H; Yavuz D; Toprak A; Akpinar I; Koç M; Deyneli O; Akalin S J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):119-23. PubMed ID: 12806595 [TBL] [Abstract][Full Text] [Related]
44. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. Lind L; Andersson PE; Andrén B; Hänni A; Lithell HO J Hypertens; 1995 Apr; 13(4):433-8. PubMed ID: 7629404 [TBL] [Abstract][Full Text] [Related]
45. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Wallace TM; Levy JC; Matthews DR Diabet Med; 2004 Jun; 21(6):568-76. PubMed ID: 15154941 [TBL] [Abstract][Full Text] [Related]
46. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Brüll V; Burak C; Stoffel-Wagner B; Wolffram S; Nickenig G; Müller C; Langguth P; Alteheld B; Fimmers R; Naaf S; Zimmermann BF; Stehle P; Egert S Br J Nutr; 2015 Oct; 114(8):1263-77. PubMed ID: 26328470 [TBL] [Abstract][Full Text] [Related]
47. The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients. Snorgaard O; Køber L; Carlsen J J Intern Med; 1997 Nov; 242(5):407-12. PubMed ID: 9408071 [TBL] [Abstract][Full Text] [Related]
48. Pioglitazone improves endothelial and adipose tissue dysfunction in pre-diabetic CAD subjects. Rizza S; Cardellini M; Porzio O; Pecchioli C; Savo A; Cardolini I; Senese N; Lauro D; Sbraccia P; Lauro R; Federici M Atherosclerosis; 2011 Mar; 215(1):180-3. PubMed ID: 21255780 [TBL] [Abstract][Full Text] [Related]
49. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension. Raptis AE; Markakis KP; Mazioti MC; Ikonomidis I; Maratou EP; Vlahakos DV; Kotsifaki EE; Voumvourakis AN; Tsirogianni AG; Lambadiari VA; Lekakis JP; Raptis SA; Dimitriadis GD Am J Hypertens; 2015 Jan; 28(1):22-9. PubMed ID: 24994608 [TBL] [Abstract][Full Text] [Related]
50. Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Bennett SM; Agrawal A; Elasha H; Heise M; Jones NP; Walker M; Wilding JP Diabet Med; 2004 May; 21(5):415-22. PubMed ID: 15089784 [TBL] [Abstract][Full Text] [Related]
51. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow. Andersson PE; Lind L; Andrén B; Hänni A; Reneland R; Berne C; Lithell H Blood Press; 1998 May; 7(2):118-26. PubMed ID: 9657539 [TBL] [Abstract][Full Text] [Related]
52. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Dogra G; Irish A; Chan D; Watts G Am J Kidney Dis; 2006 Dec; 48(6):926-34. PubMed ID: 17162147 [TBL] [Abstract][Full Text] [Related]
54. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050 [TBL] [Abstract][Full Text] [Related]
55. Rosiglitazone does not improve vascular function in subjects with chronic kidney disease. Chan DT; Watts GF; Irish AB; Dogra GK Nephrol Dial Transplant; 2011 Nov; 26(11):3543-9. PubMed ID: 21378155 [TBL] [Abstract][Full Text] [Related]
56. Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes. Moody AJ; Molina-Wilkins M; Clarke GD; Merovci A; Solis-Herrera C; Cersosimo E; Chilton RJ; Iozzo P; Gastaldelli A; Abdul-Ghani M; DeFronzo RA Diabetes Obes Metab; 2023 Feb; 25(2):426-434. PubMed ID: 36204991 [TBL] [Abstract][Full Text] [Related]
57. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome. Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. Shahin Y; Khan JA; Samuel N; Chetter I Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098 [TBL] [Abstract][Full Text] [Related]
60. The independent relationship of epicardial adipose tissue with carotid intima-media thickness and endothelial functions: the association of pulse wave velocity with the active facilitated arterial conduction concept. Kocaman SA; Durakoğlugil ME; Çetin M; Erdoğan T; Ergül E; Çanga A Blood Press Monit; 2013 Apr; 18(2):85-93. PubMed ID: 23388404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]